- $112 million of series 2013 tax-exempt revenue bonds
- $62.5 million of series 2011A revenue bonds
- $293.2 million of series 2010A revenue bonds
The rating affirmation is based on a number of factors, including Mount Sinai’s manageable debt burden, effective physician recruitment efforts and strong reputation in the New York market.
The outlook is stable.
More articles on healthcare finance:
Georgia hospital to reopen after securing last-minute buyer
Analysis finds ACA is neither victory nor catastrophe: 5 things to know
How patient engagement is affecting hospitals’ bottom lines
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
